Article Versions Notes

Pfister H, Uhlig C, Mayer Z, Polatoglou E, Randeu H, Burglechner-Praun S, Berchtold T, Sernetz S, Heitzer F, Strötges-Achatz A, et al. Long-Term Protection Against Symptomatic Omicron Infections Requires Balanced Immunity Against Spike Epitopes After COVID-19 Vaccination. Vaccines. 2025; 13(8):867. https://doi.org/10.3390/vaccines13080867

Pfister, Heiko, Carsten Uhlig, Zsuzsanna Mayer, Eleni Polatoglou, Hannah Randeu, Silke Burglechner-Praun, Tabea Berchtold, Susanne Sernetz, Felicitas Heitzer, Andrea Strötges-Achatz, and et al. 2025. "Long-Term Protection Against Symptomatic Omicron Infections Requires Balanced Immunity Against Spike Epitopes After COVID-19 Vaccination" Vaccines 13, no. 8: 867. https://doi.org/10.3390/vaccines13080867

Pfister, H., Uhlig, C., Mayer, Z., Polatoglou, E., Randeu, H., Burglechner-Praun, S., Berchtold, T., Sernetz, S., Heitzer, F., Strötges-Achatz, A., Deml, L., Sander, M., & Holdenrieder, S. (2025). Long-Term Protection Against Symptomatic Omicron Infections Requires Balanced Immunity Against Spike Epitopes After COVID-19 Vaccination. Vaccines, 13(8), 867. https://doi.org/10.3390/vaccines13080867